Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Mayes

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
American Journal of Epidemiology|April 17, 1999
Petroleum distillate solvents as risk factors for undifferentiated connective tissue disease (UCTD)J V Lacey, D H Garabrant, T J Laing, et al.
Neurogastroenterology and Motility|July 2, 2009
Gastric slow waves, gastrointestinal symptoms and peptides in systemic sclerosis patientsT A McNearney, H S Sallam, S E Hunnicutt, et al.
International Journal of Immunopathology and Pharmacology|September 27, 2013
Association of HLA-DQB1*0501 with scleroderma and its clinical features in Chinese populationX D Zhou, L Yi, X J Guo, et al.
Arthritis and Rheumatism|November 1, 1995
Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexateL W Moreland, P W Pratt, M D Mayes, et al.
American Journal of Epidemiology|October 3, 2001
Potential risk factors for undifferentiated connective tissue disease among women: implanted medical devicesT J Laing, D Schottenfeld, J V Lacey, et al.
Medicine|September 2, 2016
Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associationsS Hoa, M Hudson, Y Troyanov, et al.
Arthritis and Rheumatism|February 29, 2000
Approaches for identifying and defining environmentally associated rheumatic disordersF W Miller, E V Hess, D J Clauw, et al.
The Journal of Rheumatology|January 1, 1994
Comparison of aminobenzoate potassium and placebo in the treatment of sclerodermaD O Clegg, J C Reading, M D Mayes, et al.
The Journal of Rheumatology|November 1, 1996
The epidemiology of scleroderma among women: assessment of risk from exposure to silicone and silicaC J Burns, T J Laing, B W Gillespie, et al.
Arthritis and Rheumatism|February 14, 2012
Patterns and predictors of change in outcome measures in clinical trials in scleroderma: an individual patient meta-analysis of 629 subjects with diffuse cutaneous systemic sclerosisP A Merkel, N P Silliman, P J Clements, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
American Journal of Epidemiology|April 17, 1999
Petroleum distillate solvents as risk factors for undifferentiated connective tissue disease (UCTD)J V Lacey, D H Garabrant, T J Laing, et al.
Neurogastroenterology and Motility|July 2, 2009
Gastric slow waves, gastrointestinal symptoms and peptides in systemic sclerosis patientsT A McNearney, H S Sallam, S E Hunnicutt, et al.
International Journal of Immunopathology and Pharmacology|September 27, 2013
Association of HLA-DQB1*0501 with scleroderma and its clinical features in Chinese populationX D Zhou, L Yi, X J Guo, et al.
Arthritis and Rheumatism|November 1, 1995
Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexateL W Moreland, P W Pratt, M D Mayes, et al.
American Journal of Epidemiology|October 3, 2001
Potential risk factors for undifferentiated connective tissue disease among women: implanted medical devicesT J Laing, D Schottenfeld, J V Lacey, et al.
Medicine|September 2, 2016
Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associationsS Hoa, M Hudson, Y Troyanov, et al.
Arthritis and Rheumatism|February 29, 2000
Approaches for identifying and defining environmentally associated rheumatic disordersF W Miller, E V Hess, D J Clauw, et al.
The Journal of Rheumatology|January 1, 1994
Comparison of aminobenzoate potassium and placebo in the treatment of sclerodermaD O Clegg, J C Reading, M D Mayes, et al.
The Journal of Rheumatology|November 1, 1996
The epidemiology of scleroderma among women: assessment of risk from exposure to silicone and silicaC J Burns, T J Laing, B W Gillespie, et al.
Arthritis and Rheumatism|February 14, 2012
Patterns and predictors of change in outcome measures in clinical trials in scleroderma: an individual patient meta-analysis of 629 subjects with diffuse cutaneous systemic sclerosisP A Merkel, N P Silliman, P J Clements, et al.
Pageof 6